1. Home
  2. TARO

TARO

Taro Pharmaceutical Industries Ltd.

Logo Taro Pharmaceutical Industries Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Founded: 1959 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 1.6B IPO Year: N/A
Target Price: $43.00 AVG Volume (30 days): 52.1K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.22 EPS Growth: N/A
52 Week Low/High: $23.92 - $45.76 Next Earning Date: 05-21-2024
Revenue: $610,828,000 Revenue Growth: 7.23%
Revenue Growth (this year): 10.03% Revenue Growth (next year): N/A

Share on Social Networks: